TOXICOLOGY AND OVERDOSE OF ATYPICAL ANTIPSYCHOTICS

被引:42
|
作者
Minns, Alicia B. [1 ]
Clark, Richard F. [1 ]
机构
[1] Univ Calif San Diego, Dept Emergency Med, Div Med Toxicol, San Diego, CA 92103 USA
来源
JOURNAL OF EMERGENCY MEDICINE | 2012年 / 43卷 / 05期
关键词
atypical antipsychotic; overdose; ingestion; poisoning; NEUROLEPTIC MALIGNANT SYNDROME; TORSADE-DE-POINTES; OLANZAPINE OVERDOSE; DRUG-THERAPY; ARIPIPRAZOLE EXPOSURES; RISPERIDONE OVERDOSE; ZIPRASIDONE OVERDOSE; QUETIAPINE OVERDOSE; CASE SERIES; SCHIZOPHRENIA;
D O I
10.1016/j.jemermed.2012.03.002
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Second-generation antipsychotic medications, or "atypical antipsychotics,'' are now first-line therapy in the treatment of schizophrenia and other psychotic disorders, and are additionally being used in a wide array of other psychiatric and non-psychiatric conditions in both adults and children. Overdose is frequently reported to poison control centers. Objectives: We review the toxicology and general management of poisonings involving the atypical antipsychotic medications. Discussion: The most serious toxicity involves the cardiovascular system and the central nervous system. All typical and atypical antipsychotics cause sedation, which is pronounced in overdose. The most common cardiovascular effects that occur after atypical antipsychotic overdose are tachycardia, mild hypotension, and prolongation of the QTc interval. Other clinical syndromes in overdose include neuroleptic malignant syndrome (NMS) and antimuscarinic delirium. Seizures may be observed. No antidotes exist for these poisonings, but they most often do well with supportive care. Conclusion: Antipsychotic overdose produces a gamut of manifestations that affect multiple organ systems. Treatment is primarily supportive. Specific therapies for NMS, hypotension, and seizures are discussed. (C) 2012 Elsevier Inc.
引用
收藏
页码:906 / 913
页数:8
相关论文
共 50 条
  • [1] Fatalities Associated with Therapeutic Use and Overdose of Atypical Antipsychotics
    Adam J. Trenton
    Glenn W. Currier
    Frank L. Zwemer
    [J]. CNS Drugs, 2003, 17 : 307 - 324
  • [2] Fatalities associated with therapeutic use and overdose of atypical antipsychotics
    Trenton, AJ
    Currier, GW
    Zwemer, FL
    [J]. CNS DRUGS, 2003, 17 (05) : 307 - 324
  • [3] Overdose of Atypical Antipsychotics Clinical Presentation, Mechanisms of Toxicity and Management
    Levine, Michael
    Ruha, Anne-Michelle
    [J]. CNS DRUGS, 2012, 26 (07) : 601 - 611
  • [4] Erratum to Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management
    Michael Levine
    Anne-Michelle Ruha
    [J]. CNS Drugs, 2012, 26 (9) : 812 - 812
  • [5] Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
    DuBois, D
    [J]. CURRENT OPINION IN PEDIATRICS, 2005, 17 (02) : 227 - 233
  • [6] Atypical antipsychotics
    Naber, D
    [J]. NERVENARZT, 2000, 71 (05): : 327 - 328
  • [7] Atypical antipsychotics
    Kerwin, R
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2001, 179 : 277 - 277
  • [8] Atypical antipsychotics
    Jefferson, AM
    Markowitz, JS
    Brewerton, TD
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (12): : 1243 - 1244
  • [9] Atypical uses of atypical antipsychotics
    Brooke, NS
    Wiersgalla, M
    Salzman, C
    [J]. HARVARD REVIEW OF PSYCHIATRY, 2005, 13 (06) : 317 - 339
  • [10] Atypical or not? NMS associated with atypical antipsychotics
    Trollor, Julian
    Chen, Xiaohua
    Sachdev, Perminder
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2008, 42 : A48 - A48